All Stories

  1. Single-cell analysis reveals that cryptic prophage protease LfgB protects Escherichia coli during oxidative stress by cleaving antitoxin MqsA
  2. «Control of the phage defense mechanism by Quorum Sensing (QS) in clinical isolates ofKlebsiella pneumoniae»
  3. Phage-Defense Systems Are Unlikely to Cause Cell Suicide
  4. CRISPR-Cas Controls Cryptic Prophages
  5. Reverse Transcription-Loop-Mediated Isothermal Amplification-CRISPR-Cas13a Technology as a Promising Diagnostic Tool for SARS-CoV-2
  6. Molecular analysis of the interactions between phages and the bacterial host Klebsiella pneumoniae
  7. «Application of RT-LAMP-CRISPR-Cas13a technology to the detection of OXA-48 producing Klebsiella pneumoniae»
  8. Molecular characteristics of phages located in Carbapenemase-Producing Escherichia coli clinical isolates: New Phage-Like Plasmids
  9. The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection
  10. Adaptation of clinical isolates of Klebsiella pneumoniae to the combination of niclosamide with the efflux pump inhibitor phenyl-arginine-β-naphthylamide (PaβN): co-resistance to antimicrobials
  11. Genomic Analysis of Molecular Bacterial Mechanisms of Resistance to Phage Infection
  12. Phenotypic and Genomic Comparison of Klebsiella pneumoniae Lytic Phages: vB_KpnM-VAC66 and vB_KpnM-VAC13
  13. Enhanced Antibacterial Activity of Repurposed Mitomycin C and Imipenem in Combination with the Lytic Phage vB_KpnM-VAC13 against Clinical Isolates of Klebsiella pneumoniae
  14. Genomic Analysis of Molecular Bacterial Mechanisms of Resistance to Phage Infection
  15. «PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains inhibits lytic phage»
  16. CRISPR-Cas, a Revolution in the Treatment and Study of ESKAPE Infections: Pre-Clinical Studies
  17. CRISPR-Cas. A Revolution in the Treatment and Study of ESKAPE Infections: Pre-Clinical Studies
  18. Viral Related Tools against SARS-CoV-2
  19. Temperate Bacteriophages (Prophages) in Pseudomonas aeruginosa Isolates Belonging to the International Cystic Fibrosis Clone (CC274)
  20. Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of Klebsiella pneumoniae Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK
  21. (p)ppGpp and Its Role in Bacterial Persistence: New Challenges
  22. Whole Transcriptomic Analysis of Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of Klebsiella Pneumoniae Producers of Carbapenemase
  23. Genomic analysis of 40 prophages located in the genomes of 16 carbapenemase-producing clinical strains of Klebsiella pneumoniae
  24. In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens
  25. Strategies to Combat Multidrug-Resistant and Persistent Infectious Diseases
  26. Combined Use of the Ab105-2φΔCI Lytic Mutant Phage and Different Antibiotics in Clinical Isolates of Multi-Resistant Acinetobacter baumannii
  27. Quorum and Light Signals Modulate Acetoin/Butanediol Catabolism in Acinetobacter spp.
  28. Multiplex Real-Time PCR-shortTUB Assay for Detection of the Mycobacterium tuberculosis Complex in Smear-Negative Clinical Samples with Low Mycobacterial Loads
  29. Relationship Between Quorum Sensing and Secretion Systems
  30. Toxin Inactivation in Toxin/Antitoxin Systems
  31. Relationship Between the Quorum Network (Sensing/Quenching) and Clinical Features of Pneumonia and Bacteraemia Caused by A. baumannii
  32. Mechanisms of Bacterial Tolerance and Persistence in the Gastrointestinal and Respiratory Environments
  33. Relationship between Tolerance and Persistence Mechanisms in Acinetobacter baumannii Strains with AbkAB Toxin-Antitoxin System
  34. Evolution of the Quorum network and the mobilome (plasmids and bacteriophages) in clinical strains of Acinetobacter baumannii during a decade
  35. Clostridium difficile Infection: Pathogenesis, Diagnosis and Treatment
  36. Response to Bile Salts in Clinical Strains of Acinetobacter baumannii Lacking the AdeABC Efflux Pump: Virulence Associated with Quorum Sensing
  37. Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme
  38. Genome Sequence of AirborneAcinetobactersp. Strain 5-2Ac02 in the Hospital Environment, Close to the Species ofAcinetobacter towneri
  39. Genomic Evolution of Two Acinetobacter baumannii Clinical Strains from ST-2 Clones Isolated in 2000 and 2010 (ST-2_clon_2000 and ST-2_clon_2010)
  40. Genome Sequence of a Clinical Strain of Acinetobacter baumannii Belonging to the ST79/PFGE-HUI-1 Clone Lacking the AdeABC (Resistance-Nodulation-Cell Division-Type) Efflux Pump
  41. Toxin-Antitoxin Systems in Clinical Pathogens